Home
About
Overview
Sharing Data
ORCID
Help
History (24)
No impact of developmental conditions on serum estradiol levels among Bangladeshi women in the UK and Bangladesh.
Sample size calculations for detecting disease-modifying osteoarthritis drug effects on the incidence of end-stage knee osteoarthritis in clinical trials: Data from the Osteoarthritis Initiative.
A Goal-Concordant Prescribing Conceptual Framework: Implications for Practice and Measurement.
Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis.
The safety of rosiglitazone in the treatment of type 2 diabetes.
See All 24 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The safety of rosiglitazone in the treatment of type 2 diabetes.
Singh S, Loke YK. The safety of rosiglitazone in the treatment of type 2 diabetes. Expert Opin Drug Saf. 2008 Sep; 7(5):579-85.
View in:
PubMed
subject areas
Blood Glucose
Cardiovascular Diseases
Clinical Trials as Topic
Diabetes Mellitus, Type 2
Fractures, Bone
Heart Failure
Humans
Hypoglycemic Agents
Myocardial Infarction
Risk Factors
Thiazolidinediones
authors with profiles
Sonal Singh MD, MPH